185 related articles for article (PubMed ID: 16115875)
1. Localization of a substrate binding domain of the human reduced folate carrier to transmembrane domain 11 by radioaffinity labeling and cysteine-substituted accessibility methods.
Hou Z; Stapels SE; Haska CL; Matherly LH
J Biol Chem; 2005 Oct; 280(43):36206-13. PubMed ID: 16115875
[TBL] [Abstract][Full Text] [Related]
2. Transmembrane domains 4, 5, 7, 8, and 10 of the human reduced folate carrier are important structural or functional components of the transmembrane channel for folate substrates.
Hou Z; Ye J; Haska CL; Matherly LH
J Biol Chem; 2006 Nov; 281(44):33588-96. PubMed ID: 16923800
[TBL] [Abstract][Full Text] [Related]
3. Restoration of transport activity by co-expression of human reduced folate carrier half-molecules in transport-impaired K562 cells: localization of a substrate binding domain to transmembrane domains 7-12.
Witt TL; Stapels SE; Matherly LH
J Biol Chem; 2004 Nov; 279(45):46755-63. PubMed ID: 15337749
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a cysteine-less human reduced folate carrier: localization of a substrate-binding domain by cysteine-scanning mutagenesis and cysteine accessibility methods.
Cao W; Matherly LH
Biochem J; 2003 Aug; 374(Pt 1):27-36. PubMed ID: 12749765
[TBL] [Abstract][Full Text] [Related]
5. Functional interactions between arginine-133 and aspartate-88 in the human reduced folate carrier: evidence for a charge-pair association.
Liu XY; Matherly LH
Biochem J; 2001 Sep; 358(Pt 2):511-6. PubMed ID: 11513752
[TBL] [Abstract][Full Text] [Related]
6. Restoration of high-level transport activity by human reduced folate carrier/ThTr1 thiamine transporter chimaeras: role of the transmembrane domain 6/7 linker region in reduced folate carrier function.
Liu XY; Witt TL; Matherly LH
Biochem J; 2003 Jan; 369(Pt 1):31-7. PubMed ID: 12227830
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the membrane topology for transmembrane domains 7-12 of the human reduced folate carrier by scanning cysteine accessibility methods.
Cao W; Matherly LH
Biochem J; 2004 Feb; 378(Pt 1):201-6. PubMed ID: 14602046
[TBL] [Abstract][Full Text] [Related]
8. Identification of the minimal functional unit of the homo-oligomeric human reduced folate carrier.
Hou Z; Cherian C; Drews J; Wu J; Matherly LH
J Biol Chem; 2010 Feb; 285(7):4732-40. PubMed ID: 20018840
[TBL] [Abstract][Full Text] [Related]
9. Identification of lysine-411 in the human reduced folate carrier as an important determinant of substrate selectivity and carrier function by systematic site-directed mutagenesis.
Witt TL; Matherly LH
Biochim Biophys Acta; 2002 Dec; 1567(1-2):56-62. PubMed ID: 12488038
[TBL] [Abstract][Full Text] [Related]
10. Role of lysine 411 in substrate carboxyl group binding to the human reduced folate carrier, as determined by site-directed mutagenesis and affinity inhibition.
Deng Y; Hou Z; Wang L; Cherian C; Wu J; Gangjee A; Matherly LH
Mol Pharmacol; 2008 Apr; 73(4):1274-81. PubMed ID: 18182479
[TBL] [Abstract][Full Text] [Related]
11. Substrate-specific binding and conformational changes involving Ser313 and transmembrane domain 8 of the human reduced folate carrier, as determined by site-directed mutagenesis and protein cross-linking.
Hou Z; Wu J; Ye J; Cherian C; Matherly LH
Biochem J; 2010 Sep; 430(2):265-74. PubMed ID: 20557288
[TBL] [Abstract][Full Text] [Related]
12. Substituted cysteine accessibility of the third transmembrane domain of the creatine transporter: defining a transport pathway.
Dodd JR; Christie DL
J Biol Chem; 2005 Sep; 280(38):32649-54. PubMed ID: 16049011
[TBL] [Abstract][Full Text] [Related]
13. Substituted cysteine accessibility reveals a novel transmembrane 2-3 reentrant loop and functional role for transmembrane domain 2 in the human proton-coupled folate transporter.
Wilson MR; Hou Z; Matherly LH
J Biol Chem; 2014 Sep; 289(36):25287-95. PubMed ID: 25053408
[TBL] [Abstract][Full Text] [Related]
14. Oligomeric structure of the human reduced folate carrier: identification of homo-oligomers and dominant-negative effects on carrier expression and function.
Hou Z; Matherly LH
J Biol Chem; 2009 Jan; 284(5):3285-3293. PubMed ID: 19019821
[TBL] [Abstract][Full Text] [Related]
15. Human K562 transfectants expressing high levels of reduced folate carrier but exhibiting low transport activity.
Wong SC; McQuade R; Proefke SA; Bhushan A; Matherly LH
Biochem Pharmacol; 1997 Jan; 53(2):199-206. PubMed ID: 9037252
[TBL] [Abstract][Full Text] [Related]
16. Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.
Drori S; Jansen G; Mauritz R; Peters GJ; Assaraf YG
J Biol Chem; 2000 Oct; 275(40):30855-63. PubMed ID: 10899164
[TBL] [Abstract][Full Text] [Related]
17. Post-transcriptional regulation of the human reduced folate carrier as a novel adaptive mechanism in response to folate excess or deficiency.
Hou Z; Orr S; Matherly LH
Biosci Rep; 2014 Aug; 34(4):. PubMed ID: 24949876
[TBL] [Abstract][Full Text] [Related]
18. Analysis of membrane topology of the human reduced folate carrier protein by hemagglutinin epitope insertion and scanning glycosylation insertion mutagenesis.
Liu XY; Matherly LH
Biochim Biophys Acta; 2002 Aug; 1564(2):333-42. PubMed ID: 12175915
[TBL] [Abstract][Full Text] [Related]
19. Conformationally sensitive residues in transmembrane domain 9 of the Na+/dicarboxylate co-transporter.
Pajor AM
J Biol Chem; 2001 Aug; 276(32):29961-8. PubMed ID: 11399753
[TBL] [Abstract][Full Text] [Related]
20. Identification of dynein light chain road block-1 as a novel interaction partner with the human reduced folate carrier.
Ashokkumar B; Nabokina SM; Ma TY; Said HM
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G480-7. PubMed ID: 19571232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
